Global Non-Invasive Prenatal Testing Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends

Check out TBRC’s sale today for

The non-invasive prenatal testing market consists of sales of non-invasive prenatal testing kits, instruments and related services. Non-invasive prenatal testing kits and equipment are used to diagnose genetic abnormalities, mainly chromosome defects in fetus in first trimester of pregnancy. Non-invasive prenatal testing includes ultrasound detection, fetal cells in maternal blood tests, cell-free DNA in maternal plasma tests and biochemical screening tests.

Global Non-Invasive Prenatal Testing Market Size And Drivers:

The global non-invasive prenatal testing market is expected to grow from $2.17 billion in 2020 to $2.43 billion in 2021 at a compound annual growth rate (CAGR) of 12%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The non-invasive prenatal testing market is expected to reach $4.02 billion in 2025 at a CAGR of 13.4%. The high incidence rate of Down syndrome is one major factor driving non-invasive prenatal testing (NIPT) market with increase in average maternal age which has led to a concern on the safety about the growth of the fetus.

Request For A Sample For The Global Non-Invasive Prenatal Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp

Trends In The Global Non-Invasive Prenatal Testing Market

Next generation sequencing has increased the throughput, scalability, and speed, and further enables researchers to perform a wide range of applications and study biological systems at a higher level. Next generation sequencing is a platform that has enabled sequencing of thousands to millions of DNA molecules simultaneously. The manufacturers have introduced this technology to reduce the time and money required and optimizes the output to generate results regarding genome, DNA testing. Major companies such as Illumina, Eurofins, Natera, Roche, and Annoroad have implemented this technology in non-invasive prenatal testing. CFDA (China Food and Drug Administration) has approved the medical instrument product registration of NGS instrument NextSeq 550AR produced by Annoroad.

Global Non-Invasive Prenatal Testing Market Segments:
The global non-invasive prenatal testing market is further segmented –
By Type: Consumables, Instruments
By End User: Hospital, Diagnostic Labs
By Instruments: NGS Systems, PCR Instruments, Microarrays, Ultrasound Devices, Others (Centrifuges, UV Systems, Incubators, Microscopes)
By Consumables: Assay Kits & Reagents, Disposables
By Application: Trisomy, Microdeletion, Genetics, Rh Factor
By Geography: The global prenatal testing market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Non-Invasive Prenatal Testing Market At:

Non-Invasive Prenatal Testing Global Market Report 2021 is one of a series of new reports from that provides non-invasive prenatal testing market overviews, analyzes and forecasts market size and growth for the global non-invasive prenatal testing market, non-invasive prenatal testing market share, non-invasive prenatal testing market players, non-invasive prenatal testing market segments and geographies, non-invasive prenatal testing market’s leading competitors’ revenues, profiles and market shares. The non-invasive prenatal testing market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.